Acinetobacter lwoffi peritonitis in peritoneal dialysis: two cases report

##plugins.themes.academic_pro.article.sidebar##

Published May 19, 2022
Download
pdf
Vol. 100 No. 6 (2022): Issue Juin 2022

##plugins.themes.academic_pro.article.main##

Najla Dammak
Hanen Chaker
Ikram Agrebi
Salma Toumi
Fatma Mseddi
Khawla Kammoun
Soumaya Yaich
Mohamed Ben Hmida

Abstract

Peritonitis is an important cause of morbidity and technique failure in peritoneal dialysis. Herein, we report peritonitis related to Acinetobacter
lwoffi in two patients on peritoneal dialysis. The first case is a 63-year-old patient treated by automated peritoneal dialysis admitted with
abdominal pain. The peritoneal effluent White Blood Cells count consisted of 280 cells/mm3. Then culture identified a multisensitive Acinetobacter
lwoffi. Treatment with ceftazidime and ciprofloxacin had been started. The control dialysate culture was sterile after three weeks. The second
patient is a 59-year-old female admitted because of diffuse abdominal pain and cloudy dialysate. The peritoneal effluent White Blood Cells
count consisted of countless leukocytes, with predominantly polynuclear and culture identified Acinetobacter lwoffi. He received intraperitoneal
ceftazidim and amikacin for three weeks. The control dialysate was sterile. Acinetobacter lwoffi is a rare cause of peritonitis and it can be treated
successfully with early recognition and appropriate antibiotic therapy based on culture instead of catheter removal.


##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Polymicrobial Peritonitis in Peritoneal Dialysis Patients in Australia: Predictors, Treatment, and Outcomes. Am J Kidney Dis. Elsevier Inc.; 2010;55(1):121–31.
  2. Kim DK, Yoo TH RD et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: A single center’s experience over one decade. Perit Dial Int. 2004;24(5):424–32.
  3. Ku SC, Hsueh PR, Yang PC, Luh KT. Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2000;19(7):501–5.
  4. Singh NP, Sagar T, Nirmal K, Kaur IR. Pyogenic Liver Abscess Caused by Acinetobacter lwoffii: A Case Report. J Clin Diagn Res. 2016;10(6):DD01–2.
  5. Chao C Ter, Lee SY, Yang WS, Chen HW, Fang CC, Yen CJ, et al. Acinetobacter peritoneal dialysis peritonitis: A changing landscape over time. PLoS One. 2014;9(10):1–7.
  6. Tas MY, Oguz MM, Ceri M. Acinetobacter lwoffii Peritonitis in a Patient on Automated Peritoneal Dialysis: A Case Report and Review of the Literature. Case Reports Nephrol. 2017;
  7. Lye WC, Lee EJC, Leong SO, Kumarasinghe G. Clinical characteristics and outcome of Acinetobacter infections in CAPD patients. Perit Dial Int. 1994;14(2):174–7.
  8. Valdez JM, Asperilla MO, Smego Jr. RA. Acinetobacter peritonitis in patients receiving continuous ambulatory peritoneal dialysis. South Med J. 1991;84(5):607–10.
  9. Galvao C, Swartz R, Rocher L, Reynolds J, Starmann B, Wilson D. Acinetobacter Peritonitis During Chronic Peritoneal Dialysis. Am J Kidney Dis. 1989;14(2):101–4.
  10. Huddam B, Koçak G, Azak A, Duranay M. Acinetobacter lwoffii Peritonitis in a Patient Receiving Continuou